←
IJROBP - The Red Journal3,441 posts
IJROBP - The Red Journal avatar✓

IJROBP - The Red Journal ✓

@IJROBP

The International Journal of Radiation Oncology * Biology * Physics linkedin.com/in/ijrobp-the-r… bsky.app/profile/ijrobp

◷ Joined November 2013▧ 140 Photos and videos
ASTRO avatar
⟳ IJROBP - The Red Journal retweeted
ASTRO@ASTRO_org·Nov 14

New in #RedJournal: Adaptive SBRT boost (30 Gy/5 fx) to residual primary tumor after CRT in unresectable stage III NSCLC without immunotherapy. 2-yr OS 61.5%; BED >94.77 Gy & 3-mo SUVmax ≥4.55 predict locoregional control. tinyurl.com/rjekiraz

Post attachment
ASTRO avatar
⟳ IJROBP - The Red Journal retweeted
ASTRO@ASTRO_org·Nov 14

Check out this #RedJournal article from @NRGOnc on the neurocognitive function and quality of life results from a phase II study (NRG/RTOG 0424) of temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas. tinyurl.com/rjjswefel

Post attachment
ASTRO avatar
⟳ IJROBP - The Red Journal retweeted
ASTRO@ASTRO_org·Nov 12

🎙️ New #RedJournal Podcast: Proton Therapy Meets Clinical Trials - 11/15/2026 Editor-in-Chief Sue Yom talks with four investigators of proton therapy clinical trials. Guests include: Dr. Xing Liao, Dr. Jean Wright, Dr. Shannon Macdonald, and Dr. Nancy Mendenhall. Listen on YouTube: bit.ly/4Aws5Uo Listen on Spotify: bit.ly/4AswjfB Listen online: bit.ly/4zed7RF @IJROBP

Post attachment
Emily Lebow, MD avatar
⟳ IJROBP - The Red Journal retweeted
Emily Lebow, MD@EmilyLebow·Nov 13

Happy to share our new study in @IJROBP and presented today at @NeuroOnc, led by Dr. Lauren Linkowski, @MessingIan, Melanie Berger. Glioblastoma remains a disease with few effective therapies and often recurs within a year despite multi-modality treatment. We evaluated hypofractionated proton re-irradiation for patients with recurrent glioblastoma. 🔗 redjournal.org/article/S0360…

Post attachment
Dr Rishabh Jain avatar
⟳ IJROBP - The Red Journal retweeted
Dr Rishabh Jain@DrRishabhOnco·Nov 15

🫀 Can proton therapy make breast cancer radiotherapy safer for the heart? A 2026 review in @IJROBP highlights: 🔹 Better heart & lung sparing, especially with internal mammary node irradiation 🔹 Modern IMPT allows tailored skin-dose optimization 🔹 RADCOMP (n=1,239): Similar early quality-of-life outcomes with protons vs photons ⚠️ The big question remains unanswered: Does lower cardiac radiation translate into fewer cardiac events? The randomized long-term cardiac and cancer-control outcomes are still awaited. 💡 Verdict: Dosimetric superiority is established. Clinical superiority remains to be proven. @oncoalert #BreastCancer #RadiationOncology Full paper link in comment below ⬇️.

Post attachment
Ibrahim Chamseddine, PhD avatar
⟳ IJROBP - The Red Journal retweeted
Ibrahim Chamseddine, PhD@ibracham_·21h

1/ Radiation therapy has long been planned as if the same dose has the same effect in every tissue and every patient. In our new @IJROBP editorial with Harald Paganetti, we propose a way to change that. 🧵

ASTRO avatar
⟳ IJROBP - The Red Journal retweeted
ASTRO@ASTRO_org·Oct 30

New #RedJournal Podcast: An ASTRO Special! Productivity Metrics, Inside and Outside the RVU Sue Yom, Editor in Chief, hosts a discussion of "Measure What Matters: Rethinking Surrogate Metrics of Success in Radiation Oncology," with guests Dr. Shraddha Dalwadi and Dr. Amar Rewari. Listen on Youtube: bit.ly/4szzEqn Listen on Spotify: bit.ly/4iqTIXg Listen online: bit.ly/3W2BCUl @IJROBP @sueyom @loveandmedicine @DrAmarExplains

Post attachment
Melvin LK CHUA | FRCR, PhD, FASCO avatar
⟳ IJROBP - The Red Journal retweeted
Melvin LK CHUA | FRCR, PhD, FASCO@DrMLChua·Oct 14

#ProtonBeamTherapy has received so much visibility in recent times so this issue in the RedJ @ASTRO_org is timely edited by @sueyom Dave Carlson Thanks for the opportunity to share our experience with PBT for #NasopharyngealCarcinoma @NCCS_SG where we have treated ~250 patients to date 💪💪 We share specific scenarios where PBT is efficacious and where caution must be exercised @lachiemcd @imrtlee @mikemejiamd @seanmmcbride @xrtGenomics @DavidSherMD @DrDThomson @EChrisDee @emmaruoyii Free link to the article below! sciencedirect.com/science/ar…